Back to Journals » Drug Design, Development and Therapy » Volume 9

Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,239 | Dovepress* | 8,819+ | 1,462 | 10,281 | |
PubMed Central* | 1,420 | 421 | 1,841 | ||
Totals | 10,239 | 1,883 | 12,122 | ||
*Since 8 June 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar